Ключевые слова:
COVID-19, SARS-CoV-2, insult, ensefalopatiya, anosmiya, agevziya, polineyropatiya, nevro-inflamatsiya.Библиографические ссылки
Ellul, M. A., Benjamin, L., Singh, B., Lant, S., Michael, B. D., Easton, A., & Solomon, T. (2020). Neurological associations of COVID-19. The Lancet Neurology, 19(9), 767–783. https://doi.org/10.1016/S1 474-4422(20)30221-0
Paterson, R. W., Brown, R. L., Benjamin, L., Nortley, R., Wiethoff, S., Bharucha, T., & Zandi, M. S. (2020). The emerging spectrum of COVID-19 neurology: Clinical, radiological and laboratory findings. Brain, 143(10), 3104–3120. https://doi.org/10.109 3/brain/awaa240
Mao, L., Jin, H., Wang, M., Hu, Y., Chen, S., He, Q., & Hu, B. (2020). Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurology, 77(6), 683–690. https://doi.org/10.1001/jamaneurol.2020.1127
Misra, S., Kolappa, K., Prasad, M., Radhakrishnan, D., Thakur, K. T., Solomon, T., & Michael, B. (2021). Frequency of neurologic manifestations in COVID-19: A systematic review and meta-analysis. Neurology, 97(23), e2269–e2281. https://doi.org/ 10.1212/WNL.0000000000012930
Nath, A. (2020). Long-Haul COVID. Neurology, 95(13), 559–560. https://doi.org/10.1212/WN L.0000000000010640
Taquet, M., Geddes, J. R., Husain, M., Luciano, S., & Harrison, P. J. (2021). 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: A retrospective cohort study using electronic health records. The Lancet Psychiatry, 8(5), 416–427. https://doi.org/10.1016/S2215-0366(21) 00084-5
Lee, M. H., Perl, D. P., Nair, G., Li, W., Maric, D., Murray, H., & Nath, A. (2021). Microvascular injury in the brains of patients with COVID-19. New England Journal of Medicine, 384(5), 481–483. https: //doi.org/10.1056/NEJMc2033369
Heneka, M. T., Golenbock, D., Latz, E., Morgan, D., & Brown, R. (2020). Immediate and long-term consequences of COVID-19 infections for the development of neurological disease. Alzheimer’s Research & Therapy, 12(1), 69. https://doi.org/10.118 6/s13195-020-00640-3
Zubair, A. S., McAlpine, L. S., Gardin, T., Farhadian, S., Kuruvilla, D. E., & Spudich, S. (2020). Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019: A review. JAMA Neurology, 77(8), 1018–1027. https://doi.org/10.1001/jamaneurol.2020.2065
Helms, J., Kremer, S., Merdji, H., Clere-Jehl, R., Schenck, M., Kummerlen, C., & Meziani, F. (2020). Neurologic features in severe SARS-CoV-2 infection. New England Journal of Medicine, 382(23), 2268–2270. https://doi.org/10.1056/NEJMc2008597
Yong, S. J. (2021). Persistent brainstem dysfunction in long-COVID: A hypothesis. ACS Chemical Neuroscience, 12(4), 573–580. https://doi.org/ 10.1021/acschemneuro.0c00793
Boldrini, M., Canoll, P. D., & Klein, R. S. (2021). How COVID-19 affects the brain. JAMA Psychiatry, 78(6), 682–683. https://doi.org/10.1001/ jamapsychiatry.2021.0500
Varatharaj, A., Thomas, N., Ellul, M. A., Davies, N. W., Pollak, T. A., Tenorio, E. L., & Nicholson, T. R. (2020). Neurological and neuropsychiatric complications of COVID-19 in 153 patients: A UK-wide surveillance study. The Lancet Psychiatry, 7(10), 875–882. https://doi.org/10.1016/S2215-0366(20) 30287-X
Hosp, J. A., Dressing, A., Blazhenets, G., Bormann, T., Rau, A., Schwabenland, M., & Meyer, P. T. (2021). Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19. Brain, 144(4), 1263–1276. https://doi.org/10.10 93/brain/awab009
Silva Andrade, B., Siqueira, S., de Assis Soares, W. R., de Souza Rangel, F., Santos, N. O., dos Santos Freitas, A., & de Freitas Almeida, G. M. (2021). Long-COVID and post-COVID health complications: An up-to-date review on clinical conditions and their possible molecular mechanisms. Viruses, 13(4), 700. https://doi.org/10.3390/v13040700